Home

elhasznál Dobog nyelvtan r ipi Növelni Tört angolság Kréta

The revised International Prognostic Index (R-IPI) is a better predictor of  outcome than the standard IPI for patients with diffuse large B-cell  lymphoma. - ppt download
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma. - ppt download

The revised International Prognostic Index (R-IPI) is a better predictor of  outcome than the standard IPI for patients with diffuse large B-cell  lymphoma. - ppt download
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma. - ppt download

Table 1 from The revised International Prognostic Index (R-IPI) is a better  predictor of outcome than the standard IPI for patients with diffuse large  B-cell lymphoma treated with R-CHOP. | Semantic Scholar
Table 1 from The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. | Semantic Scholar

A New Prognostic Score for Elderly Patients with Diffuse Large B-Cell  Lymphoma Treated with R-CHOP: The Prognostic Role of Blood Monocyte and  Lymphocyte Counts Is Absent | PLOS ONE
A New Prognostic Score for Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: The Prognostic Role of Blood Monocyte and Lymphocyte Counts Is Absent | PLOS ONE

Prognostic impact of MYD88 mutation, proliferative index and cell origin in  diffuse large B cell lymphoma | Hematology, Transfusion and Cell Therapy
Prognostic impact of MYD88 mutation, proliferative index and cell origin in diffuse large B cell lymphoma | Hematology, Transfusion and Cell Therapy

Differential Impact of Relative Dose-Intensity Reductions in Diffuse Large  B-Cell Lymphoma Treated with R-CHOP21 or R-CHOP14 | PLOS ONE
Differential Impact of Relative Dose-Intensity Reductions in Diffuse Large B-Cell Lymphoma Treated with R-CHOP21 or R-CHOP14 | PLOS ONE

Relapsed/Refractory International Prognostic Index (R/R‐IPI): An  international prognostic calculator for relapsed/refractory diffuse large  B‐cell lymphoma - Maurer - 2021 - American Journal of Hematology - Wiley  Online Library
Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma - Maurer - 2021 - American Journal of Hematology - Wiley Online Library

The Enhanced International Prognostic Index for Diffuse Large B‐cell  Lymphoma | Semantic Scholar
The Enhanced International Prognostic Index for Diffuse Large B‐cell Lymphoma | Semantic Scholar

CNS International Prognostic Index: A Risk Model for CNS Relapse in  Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP | Journal  of Clinical Oncology
CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP | Journal of Clinical Oncology

Enhancement of the International prognostic index with β2-microglobulin,  platelet count and red blood cell distribution width: a new prognostic  model for diffuse large B-cell lymphoma in the rituximab era | BMC Cancer
Enhancement of the International prognostic index with β2-microglobulin, platelet count and red blood cell distribution width: a new prognostic model for diffuse large B-cell lymphoma in the rituximab era | BMC Cancer

Diffuse Large B-Cell Lymphoma in Chile: The Impact of Combined CHOP Plus  Rituximab in the Public Health System | JCO Global Oncology
Diffuse Large B-Cell Lymphoma in Chile: The Impact of Combined CHOP Plus Rituximab in the Public Health System | JCO Global Oncology

Table 2 from The revised International Prognostic Index (R-IPI) is a better  predictor of outcome than the standard IPI for patients with diffuse large  B-cell lymphoma treated with R-CHOP. | Semantic Scholar
Table 2 from The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. | Semantic Scholar

Table 1 from An enhanced International Prognostic Index (NCCN-IPI) for  patients with diffuse large B-cell lymphoma treated in the rituximab era. |  Semantic Scholar
Table 1 from An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar

Regarding R-IPI, 12%, 45%, and 43% pertained to the low, intermediate... |  Download Scientific Diagram
Regarding R-IPI, 12%, 45%, and 43% pertained to the low, intermediate... | Download Scientific Diagram

The international staging system improves the IPI risk stratification in  patients with diffuse large B-cell lymphoma treated with R-CHOP |  Scientific Reports
The international staging system improves the IPI risk stratification in patients with diffuse large B-cell lymphoma treated with R-CHOP | Scientific Reports

The revised International Prognostic Index (R-IPI) is a better predictor of  outcome than the standard IPI for patients with diffuse large B-cell  lymphoma treated with R-CHOP - ScienceDirect
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP - ScienceDirect

Diffuse Large B-Cell Lymphoma: Can We Improve Our Current Approaches to  Management?
Diffuse Large B-Cell Lymphoma: Can We Improve Our Current Approaches to Management?

International prognostic indices in diffuse large B-cell lymphoma: a  comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect

Is NCCN-IPI a Better Prognostic Tool for DLBCL Treated With R-CHOP?
Is NCCN-IPI a Better Prognostic Tool for DLBCL Treated With R-CHOP?

Revised International Prognostic Index (R-IPI) Is a Better Predictor of  Outcome Than the Standard IPI for Patients with Diffuse Large B-Cell  Lymphoma (DLBCL) Treated with Rituximab and CHOP (R-CHOP). - ScienceDirect
Revised International Prognostic Index (R-IPI) Is a Better Predictor of Outcome Than the Standard IPI for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Rituximab and CHOP (R-CHOP). - ScienceDirect

A New Prognostic Score for Elderly Patients with Diffuse Large B-Cell  Lymphoma Treated with R-CHOP: The Prognostic Role of Blood Monocyte and  Lymphocyte Counts Is Absent | PLOS ONE
A New Prognostic Score for Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: The Prognostic Role of Blood Monocyte and Lymphocyte Counts Is Absent | PLOS ONE

Distribution of patients inside risk groups and OS by standard IPI [8],...  | Download Table
Distribution of patients inside risk groups and OS by standard IPI [8],... | Download Table

MYC and BCL-2 adjusted-International Prognostic Index (A-IPI) is a better  predictor of outcome than the standard IPI for patients with diffuse large  B-cell lymphoma treated with R-CHOP. | Semantic Scholar
MYC and BCL-2 adjusted-International Prognostic Index (A-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. | Semantic Scholar

Distribution of patients inside risk groups and OS by standard IPI [8],...  | Download Table
Distribution of patients inside risk groups and OS by standard IPI [8],... | Download Table

Frontiers | The Application of the Lymphoma International Prognostic Index  to Predict Venous Thromboembolic Events in Diffuse Large B-Cell Lymphoma  Patients
Frontiers | The Application of the Lymphoma International Prognostic Index to Predict Venous Thromboembolic Events in Diffuse Large B-Cell Lymphoma Patients

Response to treatment according to different R-IPI categories | Download  Table
Response to treatment according to different R-IPI categories | Download Table

The International Prognostic Index (IPI) [117] and age-adjusted IPI... |  Download Table
The International Prognostic Index (IPI) [117] and age-adjusted IPI... | Download Table

EHA Library - The official digital education library of European Hematology  Association (EHA)
EHA Library - The official digital education library of European Hematology Association (EHA)

Improving Outcomes and Evaluating Novel Treatment Approaches for Patients  With DLBCL or MCL (Transcript)
Improving Outcomes and Evaluating Novel Treatment Approaches for Patients With DLBCL or MCL (Transcript)

Comparison of factors and scoring of IPI, NCCN-IPI, and GELTAMO-IPI |  Download Table
Comparison of factors and scoring of IPI, NCCN-IPI, and GELTAMO-IPI | Download Table